These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10157682)

  • 1. Management of high blood cholesterol.
    Smith MD; McGhan WF
    Bus Health; 1996 Apr; 14(4):67-8, 70, 72-4. PubMed ID: 10157682
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the value and affordability of cholesterol reduction in the managed care setting.
    Gonzalez ER; Kannewurf BS
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S226-33; quiz S234-5. PubMed ID: 10180344
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-cost intervention produces dramatic results in managing LDL cholesterol.
    Dis Manag Advis; 2001 Mar; 7(3):36-9, 33. PubMed ID: 11299511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heartsick America.
    Cowley G
    Newsweek; 2001 May; 137(22):43. PubMed ID: 11393041
    [No Abstract]   [Full Text] [Related]  

  • 5. The economics of lipid management.
    Mullins CD
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines.
    Armstrong DW; Brouillard D; Matangi MF
    Can J Cardiol; 2011; 27(2):167-70. PubMed ID: 21459264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.
    Hunninghake DB; McKenney JM; Gotto AM; Mehta JL; Jones PH
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S1008-16. PubMed ID: 11187369
    [No Abstract]   [Full Text] [Related]  

  • 10. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic principles of cost-benefit analysis in long-term treatment of risk factors].
    Szucs TD; Gutzwiller F
    Schweiz Med Wochenschr; 1998 Dec; 128(49):1958-64. PubMed ID: 9887476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.
    Tsevat J; Kuntz KM; Orav EJ; Weinstein MC; Sacks FM; Goldman L
    Am Heart J; 2001 May; 141(5):727-34. PubMed ID: 11320359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously].
    MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.
    Willich SN; Müller-Nordhorn J; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H
    Am Heart J; 2004 Dec; 148(6):1060-7. PubMed ID: 15632894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source].
    MMW Fortschr Med; 2005 Jun; 147(23):48-9. PubMed ID: 15981908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reduction of cholesterol and myocardial infarction. Big differences between different groups when it comes to the therapeutic effect].
    Håkansson J
    Lakartidningen; 1997 Dec; 94(49):4619, 4622-3. PubMed ID: 9445934
    [No Abstract]   [Full Text] [Related]  

  • 17. Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.
    Goldberg KC; Melnyk SD; Simel DL
    Am J Manag Care; 2007 Sep; 13(9):530-4. PubMed ID: 17803367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significant decline in the rate of cardiovascular incidents].
    Wedekind S
    MMW Fortschr Med; 2015 Jun; 157(11):66. PubMed ID: 26049360
    [No Abstract]   [Full Text] [Related]  

  • 20. Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Robinson JG; Stone NJ
    Am J Cardiol; 2006 Nov; 98(10):1405-8. PubMed ID: 17134640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.